FluoroPharma Medical, Inc. (FPMI) to Report Preclinical Data on Alzheimer’s Disease and Prostate Cancer PET Imaging Agents
FluoroPharma, Inc. announced today that Dr. David Elmaleh, FluoroPharma’s founder and Chief Scientific Advisor, will report on two preclinical studies…